Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Tack

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
JAMA|March 19, 1982
The inhibitory quotientK J Tack
Lancet (London, England)|December 12, 1981
Possible tampon-associated toxic shock syndrome in a manK J Tack
The American Journal of Medicine|December 29, 1989
The safety profile of ofloxacinK J Tack, J A Smith
Chemotherapy|January 1, 1985
Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycinK J Tack, L D Sabath
Antimicrobial Agents and Chemotherapy|June 1, 1991
Accidental overdose of intravenous ofloxacin with benign outcomeR B Kohler, N Arkins, K J Tack
Drugs|January 1, 1995
Initial clinical experience with clinafloxacin in the treatment of serious infectionsK J Tack, N M McGuire, I A Eiseman
Antimicrobial Agents and Chemotherapy|February 13, 2001
Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infectionsG Siami, N Christou, I Eiseman, et al.
Infection|January 1, 1986
Clinical experience with ofloxacin in urinary tract infectionC E Cox, S V Callery, K J Tack
Infection|January 1, 1986
Clinical experience with ofloxacin in sexually transmitted diseaseF N Judson, B S Beals, K J Tack
Southern Medical Journal|July 1, 1983
Antibiotic susceptibility of S aureus isolates in a community hospitalR C Gordon, K J Tack, R Wofford, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
JAMA|March 19, 1982
The inhibitory quotientK J Tack
Lancet (London, England)|December 12, 1981
Possible tampon-associated toxic shock syndrome in a manK J Tack
The American Journal of Medicine|December 29, 1989
The safety profile of ofloxacinK J Tack, J A Smith
Chemotherapy|January 1, 1985
Increased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycinK J Tack, L D Sabath
Antimicrobial Agents and Chemotherapy|June 1, 1991
Accidental overdose of intravenous ofloxacin with benign outcomeR B Kohler, N Arkins, K J Tack
Drugs|January 1, 1995
Initial clinical experience with clinafloxacin in the treatment of serious infectionsK J Tack, N M McGuire, I A Eiseman
Antimicrobial Agents and Chemotherapy|February 13, 2001
Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infectionsG Siami, N Christou, I Eiseman, et al.
Infection|January 1, 1986
Clinical experience with ofloxacin in urinary tract infectionC E Cox, S V Callery, K J Tack
Infection|January 1, 1986
Clinical experience with ofloxacin in sexually transmitted diseaseF N Judson, B S Beals, K J Tack
Southern Medical Journal|July 1, 1983
Antibiotic susceptibility of S aureus isolates in a community hospitalR C Gordon, K J Tack, R Wofford, et al.
Pageof 4